Instructions for Logacer (Choline alfoscerate)
Dosage form
transparent colorless or yellowish liquid.
Composition
1 ml of solution contains:
Active substance:
Choline alfoscerate hydrate
(per choline alfoscerate) - 250.0 mg
Auxiliary substance:
Water for injection up to 1.0 ml
Pharmacotherapy group Choline alfoscerate
nootropic agent
Pharmacodynamics Choline alfoscerate
Choline alfoscerate is a central-acting cholinomymetic with a predominant effect on the central nervous system. The drug contains 40.5% choline, released from the compound in the brain; choline is involved in the biosynthesis of acetylcholine (one of the major nerve mediators).
Testimony Choline alfoscerate
- psychoorganic syndrome amid involutive and degenerative processes in the brain;
- Effects of cerebrovascular insufficiency or primary and secondary cognitive impairment in older persons,
- characterized by memory impairment,
- confusion, disorientation,
- reduced motivation and initiative,
- decreased attention concentration;
- Disorders of behavior and affective sphere in old age:
- emotional lability,
- increased irritability,
- decreased interest;
- an old pseudo-melancholy.
Method of use and doses Choline alfoscerate
The preparation is administered intramuscularly or intravenously (drip, slow).
Adults. Intramuscularly or intravenously in a dose of 1000 mg (1 ampoule) per day. When intravenously introduced, the contents of one ampoule (four ml) are diluted in fifty ml of 0.9% chloride sodium solution, an infusion rate of sixty - eighty drops per minute.
